Table 3.
Human-related factors related to acceptance (N=77) of medical AIa applications (14/32, 43.8%, studies).
| Factor category and factors from the rapid review | Umbrella factors used in the survey | ||
| AI professionals | |||
|
|
AI company/provider (n=1, 7.1%); brand impact (n=1, 7.1%) | Type of institution/organization of AI professionals (eg, university, technology company, commercial organization) | |
|
|
Perceived usefulness (n=3, 21.4%); better medical services/ understanding of disease (n=3, 21.4%); improve the quality of people’s lives (n=2, 14.3%); medical costs (n=2, 14.3%); AI role (eg, saving patients’ time; n=1, 7.1%); miniaturization of hardware (n=1, 7.1%) | Purpose to innovate with a specific AI application in medicine (eg, financial vs societal) | |
| Health care professionals | |||
|
|
Knowledge and understanding of AI (n=1, 7.1%) | Knowledge of AI applications in medicine (eg, by means of training and education) | |
|
|
Behavioral intention to use (n=2, 14.3%); effort expectancy (n=2, 14.3%); perceived ease of use (n=2, 14.3%); perceived usefulness (n=2, 14.3%); intrinsic motivation (n=1, 7.1%); interest in AI (n=1, 7.1%); professional identity (n=1, 7.1%); concerns about benefit to patient care (n=1, 7.1%); general impression of AI (n=1, 7.1%) | Attitude toward AI application usage in medicine (eg, agreeableness, openness, conscientiousness, engagement) | |
| Patients informed about AI application usage in the hospital | |||
|
|
Knowledge/education about AI (n=1, 7.1%); awareness of AI (n=1, 7.1%) | General knowledge of AI applications in medicine | |
|
|
Behavioral intention to use (n=2, 14.3%); general impression (n=1, 7.1%); Interest in topic (n=1, 7.1%) | Attitude toward AI application usage in medicine (eg, agreeableness, openness, conscientiousness) | |
|
|
Age (n=1, 7.1%) | Age | |
| All parties | |||
|
|
Expectations of others (n=2, 14.3%) | Transparency between all involved parties (AI professionals, healthcarehealth care professionals, patients) | |
aAI: artificial intelligence.